Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00PUT
|
|||
| Former ID |
DIB006313
|
|||
| Drug Name |
BT-016
|
|||
| Synonyms |
Tregalizumab
Click to Show/Hide
|
|||
| Indication | Rheumatoid arthritis [ICD-11: FA20] | Phase 2 | [1] | |
| Company |
Abbvie
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01999192) Study to Investigate the Safety and Efficacy of Tregalizumab in Subjects (MTX-IR) With Active Rheumatoid Arthritis. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.